The periodontal pathogen Porphyromonas gingivalis (Pg) is a potent inducer of the production of pro-inflammatory cytokines by neutrophils, monocytes, and macrophages, and can desensitize immune cells in vitro and in vivo. We analyzed the ability of Pg lipopolysaccharide (LPS) to induce endotoxin tolerance. Treatment of dendritic cells (DC), the human macrophage cell line THP-1, and monocytes (antigen-presenting cells, APC) with Pg.LPS inhibited APC maturation assessed by CD80 and CD86 expression, and inhibited chemokine (CCL3 and CCL5) production. Pre-treatment with glucocorticoids (GC) and interleukin-10 (IL-10) abolished the effect of Pg.LPS on CD80, CD83, and CD86, and on CCL3 and CCL5 production. We also showed that Pg.LPS enhanced the tolerogenic properties of APCs and up-regulated ILT-3 and B7-H1 expression.
Get full access to this article
View all access options for this article.
References
1.
Aderem A, Ulevitch RJ (2000). Toll-like receptors in the induction of the innate immune response. Nature406:782–787.
2.
Akira S, Takeda K, Kaisho T (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol2:675–680.
3.
Banchereau J, Steinman RM (1998). Dendritic cells and the control of immunity. Nature392:245–252.
4.
Berrebi D, Bruscoli S, Cohen N, Foussat A, Migliorati G, Bouchet-Delbos L, et al. (2003). Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood101:729–738.
5.
Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, et al. (1997). A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med185:1743–1751.
6.
Clark WB, Löe H (1993). Mechanisms of initiation and progression of periodontal disease. Periodontol 20002:72–82.
Darveau RP, Cunningham MD, Bailey T, Seachord C, Ratcliffe K, Bainbridge B, et al. (1995). Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun63:1311–1317.
9.
Deshpande RG, Khan MB, Genco CA (1998). Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun66:5337–5343.
10.
Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, et al. (2003). Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR “homotolerance” versus “heterotolerance” on NF-kappa B signaling pathway components. J Immunol170:508–519.
11.
Dong H, Zhu G, Tamada K, Chen L (1999). B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med5:1365–1369.
12.
Golenbock DT, Fenton MJ (2001). Extolling the diversity of bacterial endotoxins. Nat Immunol2:286–288.
13.
Hajishengallis G, Martin M, Schifferle RE, Genco RJ (2002). Counteracting interactions between lipopolysaccharide molecules with differential activation of toll-like receptors. Infect Immun70:6658–6664.
14.
Hanazawa S, Kawata Y, Takeshita A, Kumada H, Okithu M, Tanaka S, et al. (1993). Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun61:5219–5224.
15.
Huang GT, Haake SK, Kim JW, Park NH (1998). Differential expression of interleukin-8 and intercellular adhesion molecule-1 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans or Porphyromonas gingivalis infection. Oral Microbiol Immunol13:301–309.
16.
Jagels MA, Ember JA, Travis J, Potempa J, Pike R, Hugli TE (1996). Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor. Adv Exp Med Biol389:155–164.
17.
Jiang Y, Mehta CK, Hsu TY, Alsulaimani FF (2002). Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun70:3143–3148.
18.
Jotwani R, Palucka AK, Al-Quotub M, Nouri-Shirazi M, Kim J, Bell D, et al. (2001). Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol167:4693–4700.
19.
Kitamura Y, Matono S, Aida Y, Hirofuji T, Maeda K (2002). Gingipains in the culture supernatant of Porphyromonas gingivalis cleave CD4 and CD8 on human T cells. J Periodontal Res37:464–468.
20.
Kumar PS, Griffen AL, Barton JA, Paster BJ, Moeschberger ML, Leys EJ (2003). New bacterial species associated with chronic periodontitis. J Dent Res82:338–344.
21.
Lappin DF, MacLeod CP, Kerr A, Mitchell T, Kinane DF (2001). Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clin Exp Immunol123:294–300.
Muzio M, Bosisio D, Polentarutti N, D’Amico G, Stoppacciaro A, Mancinelli R, et al. (2000). Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol164:5998–6004.
24.
Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC (1998). Dendritic cells as the terminal stage of monocyte differentiation. J Immunol160:4587–4595.
25.
Shortman K, Heath WR (2001). Immunity or tolerance? That is the question for dendritic cells. Nat Immunol2:988–989.
26.
Stordeur P, Goldman M (1998). Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects. Int Rev Immunol16:501–522.
27.
Sugawara S, Nemoto E, Tada H, Miyake K, Imamura T, Takada H (2000). Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J Immunol165:411–418.
28.
Ulevitch RJ, Tobias PS (1995). Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol13:437–457.
29.
Wagner H (2001). Toll meets bacterial CpG-DNA. Immunity14:499–502.
30.
Zhang G, Ghosh S (2001). Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest107:13–19.
